.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
QuintilesIMS
Healthtrust
Covington
Dow
Moodys
Accenture
Cerilliant
Fish and Richardson

Generated: November 19, 2017

DrugPatentWatch Database Preview

Vitarine Company Profile

« Back to Dashboard

What is the competitive landscape for VITARINE, and what generic and branded alternatives to VITARINE drugs are available?

VITARINE has forty-two approved drugs.



Summary for Vitarine

US Patents:0
Tradenames:23
Ingredients:23
NDAs:42
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
TABLET;ORAL085837-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
TABLET;ORAL085519-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
TABLET;ORAL086106-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
CAPSULE;ORAL061387-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
TABLET;ORAL086088-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
AMPICILLIN TRIHYDRATE
ampicillin/ampicillin trihydrate
CAPSULE;ORAL061387-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PREDNISONE
prednisone
TABLET;ORAL080334-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
BROMPHENIRAMINE MALEATE
brompheniramine maleate
TABLET;ORAL085850-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL087235-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL086456-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Cantor Fitzgerald
Express Scripts
UBS
McKesson
Baxter
Argus Health
Accenture
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot